You can access the original SEC filing by clicking here.
Ownership Summary Table
|Name||Sole Voting Power||Shared Voting Power||Sole Dispositive Power||Shared Dispositive Power||Aggregate Amount Owned Power||Percent of Class|
|Armistice Capital Master Fund Ltd||0||1,614,000||0||1,614,000||1,614,000||9.9%|
Follow Steven Boyd's Armistice Capital
Page 1 of 10 – SEC Filing
Eyegate Pharmaceuticals, Inc.
(Name of Issuer)
Common Stock, $0.01 par value per share
(Title of Class of Securities)
June 9, 2017
(Date of Event Which Requires Filing of this Statement)